•
Jun 30, 2022

Sanara MedTech Q2 2022 Earnings Report

Generated record revenue in the second quarter of 2022.

Key Takeaways

Sanara MedTech reported record revenue in Q2 2022, marking the first quarter with over $3 million in sales each month. The company also completed the acquisition of Scendia Biologics, LLC.

Generated record revenue in the second quarter of 2022.

Achieved over $3 million in sales in each month during the quarter.

Acquired Scendia Biologics, LLC.

Integrated the Scendia team and biologic products into Sanara.

Total Revenue
$9.67M
Previous year: $6.28M
+54.1%
EPS
-$0.42
Previous year: -$0.16
+162.5%
Gross Profit
$8.71M
Previous year: $5.74M
+51.8%
Cash and Equivalents
$12.7M
Previous year: $24.4M
-48.0%
Free Cash Flow
-$1.19M
Previous year: -$355K
+235.0%
Total Assets
$46.5M
Previous year: $38.8M
+19.8%

Sanara MedTech

Sanara MedTech